Delivery Order SPE2DB24D1205-SPE2DB24FCUPG
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of 1,000 capsules of the pharmaceutical drug Tamsulosin HCl 0.4 mg. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The award has a ceiling value of $2,631.63 and is a firm fixed-price delivery order with a completion date of July 16, 2025. The contract is not set aside and is an open competition....
This federal contract award is for the delivery of 1,000 units of the pharmaceutical product Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA). The $3,215.30 fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corporation's Corporate Office division, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is for the delivery of 4,563,310,435 units of Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA), which is a defense agency. The contract was awarded on January 11, 2024, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $1,541.82. This is a delivery order contract with a firm fixed price, and the ultimate completion date is January 12, 2024. The contract does not have a set-aside designation, indicating open...
This federal contract award is a delivery order valued at $1,443.94, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules, with a performance period ending on May 15, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and no subcontractors...
This federal contract award is for the supply of 4,566,816,352 units of the drug Tamsulosin HCL 0.4 mg capsules, valued at $1,087.28, with a completion date of January 2, 2025. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. It is not designated with a set-aside requirement,...
This federal contract award is for the delivery of Tamsulosin HCL 0.4 mg capsules (1,000 per order) to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $2,286.66 and is set to expire on September 21, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $2,353.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the supply of Tamsulosin HCl 0.4 mg capsules and has a firm fixed price. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award, valued at $1,548.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,986,316 units of Tamsulosin HCL 0.4 mg capsules. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC, valued at up...
This federal contract award is for the delivery of 1,000 capsules of the prescription medication Tamsulosin Hydrochloride 0.4 mg. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The total ceiling value of the contract is $4,995.20, and it is structured as a firm fixed-price delivery order. The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,691.50 firm fixed-price delivery order covers the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat urinary issues. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division....